Endeavour Vision’s $375 Million Launch of Endeavour Medtech Growth II LP

Carey Olsen, working alongside Clifford Chance (Munich), has advised leading venture capital and growth equity firm Endeavour Vision on the successful launch and final close of its second dedicated medtech and digital health fund, Endeavour Medtech Growth II (EMG II) LP, with commitments of US$375 million.The EMG II LP fund will continue the strategy of its US$250 million predecessor (Endeavour Medtech Growth LP) by investing in high-potential European and US companies delivering transformative healthcare technologies to improve the standard of care for patients and bring efficiencies to healthcare systems. In particular, the fund will focus on growth stage companies that have overcome clinical and regulatory hurdles and are starting to generate commercial traction.

The Carey Olsen team was led by partner David Crosland (Picture) with assistance from senior associate Alex Mauger. 
Involved fees earner: David Crosland – Carey Olsen; Alex Mauger – Carey Olsen; Law Firms: Carey Olsen; Clients: Endeavour Vision;

Author: Giulia Di Palma